Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning (Companion Faculty Lecture)

<p class="MsoNormal">Featuring a slide presentation and related discussion from Dr Matthew Lunning, including the following topics:</p> <ul> <li>Overview of available chimeric antigen receptor (CAR) T-cell therapies (0:00)</li> <li>Toxicities associated with CAR T-cell therapy (4:03)</li> <li>Mitigation strategies for adverse events (22:02)</li> <li>Novel strategies for outpatient infusion (26:34)</li> <li>Changes to the CAR T-cell therapy safety regulations (30:23)</li> </ul> <p class="MsoNormal"><a href= "http://m.researchtopractice.com/OncologyTodayCARTSafety25/Presentation"> CME information and select publications</a></p>